Tasnim Iranian-made Remdesivir, an antiviral medication for the treatment of coronavirus patients, will be put on the market within the next few days, an official said. Head of the Food and Drug Administration of Iran Mohammadreza Shanesaz announced on Monday that the homegrown Remdesivir will be distributed among the hospitals within the next ...

FNA - Head of Food and Drug Administration of Iran (FDA) Mohammad Reza Shanesaz announced on Friday that three Iranian companies are ready to make the antiviral drug Favipiravir, which is said to be effective in the treatment of COVID-19. Shanesaz said that production of Favipiravir in Iran is in the phase of clinical trials and as planned its basic ...

Press TV - Head of the Food and Drug Administration of Iran says the country is bartering medicine produced in the country with food imported from South America. Mohammad Reza Shanesaz, a deputy health minister, said on Wednesday that a main aim of the barter program was to help Iranian pharmaceutical companies to thrive by providing them with a ...

IRNA Head of Food and Drug Administration of Iran Mohammad Reza Shanesaz said on Wednesday that the US still continues creating obstacles to prevent export of pharmaceutical drugs to Iran. Speaking in the 3rd international congress on modern pharmacology which was held in Razi International Conference Center of Tehran, Mohammad Reza Shanesaz said ...

MNA In a ceremony on Sunday and with participation of Head of Food and Drug Administration of Iran (IFIDA), first domestically produced pulmonary surfactant Beraksurf was unveiled. Production of this drug requires high technological knowledge and has cost $4.5 million to $5 million, IFIDA Head Mohamamdreza Shanehsaz said. Despite the challenges ...